Sam Ghilardi 5/26/26 Sam Ghilardi 5/26/26

Watertown's First Potential IPO since 2023, Remix's Positive Clinical Trial Results, and Triveni Jumps into the Eczema Market

Plus the initial dosing of Enanta and Avencell's Clinical Trials

Watertown Bio